Member Info for MisterPositive

Shares in high demand here....Not many about. They have to get them from the market.

With transformational news expected on not 1 but all 3 projects....you gotta be crazy to be selling now. Back to back RNS and Christmas will come early for us 😁

Things about to get very lively here. Still flying under the radar while position building continues in Stealth mode.

80M.LN with free carry on drilling of first 2 Oil wells by GLND to earn 70% of the large 2m acres Jameson Land basin licence share with potential "multi-billion" barrels untapped resource. Upto 50 drill targets identified after ARCO's reprocessed 2D data.

Oil strike on 1st well and rest...you can imagine !!

"The move positions the new entity as the first U.S. public company dedicated to advancing oil and gas development in Greenland’s Jameson Land Basin, a region long considered one of the most promising undrilled hydrocarbon basins in the Arctic. "

Pelican Acquisition Corp IPO in May 2025 on NASDAQ was priced at $10 per share raising US$75m of capital.

I would expect Greenland Energy IPO this QTR to be priced similar level to PELI and expect to raise circa $100m from US investors. IMHO.

Background buying going on "Stealth mode".

At this rate this could trickle higher to 0.70 by Friday ahead of news.

Herd has not even arrived yet...😁

Stay tuned folks for a busy QTR.

Expect lot of US investment capital ($$$) making its way via Greenland energy listing on the NASDAQ (ticker: GLND)

80M has 100% licence.

"With rights to own up to 70% of three onshore licenses covering more than two million acres, Greenland Energy is positioned to lead one of the most significant oil and gas ventures in the Arctic".

https://worldoil.com/news/2025/9/11/215-million-merger-forms-greenland-energy-to-unlock-arctic-drilling-potential/

This is the Dark Horse that could surprise everyone in coming days / weeks with news incoming on "Multiple" fronts.

Consolidated beautifuly over past 4 weeks after hitting intra-day high of 0.80 early Sep and now looking primed for a breakout surpassing 0.80 en route to 1p first stop OR lot higher depending on expected newsflow.

Bluejay Mining Plc Stock (BLLYF) Price Forecast for 2025

Bluejay Mining Plc Stock (BLLYF) is expected to reach an average price of $0.0563 in 2025, with a high prediction of $0.0874 and a low estimate of $0.0251. This indicates an +603.22% rise from the last recorded price of $0.008.

https://stockscan.io/stocks/BLLYF

NASDAQ listing coming up for GLND.

Wonder what price will that be listed at on the NASDAQ ?

I have Doubled my Holding here adding under 2p and taking up my full 1 for 1 entitlement also.

Been extremely busy lately so not had time to post but browse through the comments here from time to time.

Despite placing coming at 1.5p instead of 3p...future is looking very bright here. Even with 400m extra shares to be added to current 143m shares....total shares in issue will still be low 543m which is nothing compared to some other companies with over 20 Billion shares about.

Once £6m is in the bank...this should move higher quite rapidly this summer ahead of 10 July NICE recommendation publication date. So just add or sit tight. This can get to well over £100m MCap pretty quickly as Sales start to increase substantially over coming 6-12 months. We got a target market of £300m in Annual revenues.

You will look back next year and say why the he11 did I not get more shares in 2024 at all time lows.

Good Luck all & the very best for the future.

MP

More scaremongering from the usual suspects.

Better close your Short position....SLACK.

AIHL tests for FDA in the USA is a separate process compared to AIHL tests in UK and Europe where sales have started and will increase further with more take up in coming months. But you knew that already didn't you !!!

Lionel. Great posts. Future looking very bright.

Future is Pharmacogenomics and GDR is well positioned now after years of research and product development now with 2 quality life saving tests to come to market.

Pharmacogenomics market to hit US$40 Billion by 2033. GDR should capture a decent share of it.

BigAl

Good post. Some on this board twisting facts for their own obvious agenda for a lower entry. Some have made it too obvious.

In my own view, we would be raise funds at a higher price from current 6p after some positive updates soon.

Only got 143m shares in issue currently. Lets say they issue another 60m shares @ 10p to raise £6m....that would be circa 200m shares in total.

I will be happy to participate @ 10p and wait for £1.00 when MCap gets to £200m unless bought earlier by Pharma with lowball cheap offer @ 40p

Genedrive is finally on the cusp of generating substantial revenues from its 2 quality products - AIHL tests and STROKE tests.

AIHL being totally exclusive and first to market for Genedrive with NO competition.

GloriaMarket - wild ongoing speculation from you in the past 2 weeks about de-listing and taking company private ???

Far from it - all companies list on AIM to generate funding for Expansion and growth. It takes years for Bio-tech companies to develop breakthrough technology which Genedrive has now got with not one but 2 quality products. Sales will increase substantially as more NHS sites come on board. UK market alone is HUGE for Genedrive before adding Europe, USA, Middle East, Asia Pacific and rest of the world.

Tiger16

Stroke test full NICE recommendation publication date is by 10 July.

But my strong opinion is we could hear headline announcement from NICE soon after 26 April when final Consultation period ends with full report to be published by 10 July.

Will also not rule out a surprise TakeOver approach in the near future soon after STROKE tests recommendation from NICE this year.

Next Operational update / interim results should also confirm increasing Revenues trajectory from AIHL tests before Stroke test Revenues kick in.

Get ready for some updates soon.

Revenues increasing with more take up and additional sites going live.

Update on Stroke Tests full recommendation is going to blow this way way higher in coming weeks.

Full recommendation from NICE could also attract BuyOut opportunities for Big Pharma to take both AIHL and STROKE test market under their wings.

Roger65

Good to see a positive post from you after a long time. Very refreshing. I think there is defo more traction on AIHL and higher take up. NHS despite being slow is finally catching up and we should see higher sales revenues going forward from UK, and hopefully from both Europe and MiddleEast.

Next Operational update should provide more details.

Stroke tests should start generating revenues much earlier than i think. NICE full recommendation is not far now. Public consultation period started May 2023 and about to end on 26 April 2024. Genedrive expect no change in NICE draft recommendation received just recently.

Expect STROKE tests full NICE recommendation news headline soon after 26 April 2024.

Publication date is by 10 July or earlier.

Fully expect this to trickle higher back towards +10p within next 2 weeks ahead of 26 Apr 2024 as punters start taking positions again.

Lionel.

Some very good posts. Very much appreciated by many here. Keep up the good work.

There lot of doom mongers back like Leeches, looking for their lower entry....always a good sign. On top of dealing with Slacker- The Slack and Roger - The dodger.

Consultation period ends on 26 April 2024 in just over 2 weeks.

Full recommendation for STROKE tests by NICE. Expect headline news announcement soon after end of April with full report to be published by 10 July 2024.

This will push higher earlier than some think.